Jushi Holdings Inc. filed a Current Report on Form 8-K dated November 10, 2026, to disclose an updated investor presentation. The document, filed with the U.S. Securities and Exchange Commission, outlines the company's strategic focus for the remainder of 2026 and 2027, highlighting Virginia as a primary growth catalyst.
The presentation details Jushi's operational results as of September 30, 2026. The company reported a trailing twelve-month (LTM) revenue of approximately $277 million and an adjusted EBITDA of roughly $52 million. Jushi operates 42 stores across eight markets, including medical cannabis operations in Pennsylvania and Virginia, and adult-use operations in Ohio, Massachusetts, Nevada, Illinois, New Jersey, and California.
Key strategic priorities identified in the filing include:
- Virginia Adult-Use Launch: Adult-use cannabis sales are expected to commence on July 1, 2027. The company plans to position retail and inventory levels for this launch and expand its cultivation and processing facilities.
- Capital Allocation: The company intends to fund all activities with balance sheet cash, delaying additional third-party financing until regulatory clarity is achieved.
- Facility Expansion: Jushi is expanding its cultivation capacity in Virginia, adding hydrocarbon extraction capabilities and planning a new warehouse expansion to support adult-use operations.
The filing also notes that Jushi completed a non-dilutive debt refinancing of $160 million in March 2026 and redomiciled from British Columbia to Nevada in July 2026. The company continues to trade under the ticker symbol “JUSH” on the Canadian Securities Exchange and OTCQX.
